The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Infertility Diagnosis-Global Market Insights and Sales Trends 2024

Infertility Diagnosis-Global Market Insights and Sales Trends 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1851994

No of Pages : 102

Synopsis
Fertility diagnosis is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are performed based on the completion of this three step process. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned regarding fertility diagnosis.
The global Infertility Diagnosis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infertility Diagnosis in various end use industries. The expanding demands from the Hospitals, Clinics, Fertility Centers and Research Institutes, are propelling Infertility Diagnosis market. Female Infertility Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Male Infertility Testing segment is estimated at % CAGR for the next seven-year period.
Decline in fertility rates, increasing number of fertility clinics, rising number of gynecological disorders and technological advancements and innovative testing products are expected to drive the growth of the market in the coming years. Increasing awareness among the female population is expected to offer growth opportunities for the manufacturers operating in the market during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infertility Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infertility Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infertility Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infertility Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infertility Diagnosis covered in this report include Merck, Procter & Gamble, BioMerieux, Abbott, Babystart, BioZhena Corporation, Quidel Corporation, SPD Swiss Precision Diagnostics GmbH and SCSA Diagnostics, etc.
The global Infertility Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Procter & Gamble
BioMerieux
Abbott
Babystart
BioZhena Corporation
Quidel Corporation
SPD Swiss Precision Diagnostics GmbH
SCSA Diagnostics
Pride Angel
Global Infertility Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infertility Diagnosis market, Segment by Type:
Female Infertility Testing
Male Infertility Testing
Global Infertility Diagnosis market, by Application
Hospitals
Clinics
Fertility Centers
Research Institutes
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infertility Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Infertility Diagnosis
1.1 Infertility Diagnosis Market Overview
1.1.1 Infertility Diagnosis Product Scope
1.1.2 Infertility Diagnosis Market Status and Outlook
1.2 Global Infertility Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infertility Diagnosis Market Size by Region (2018-2029)
1.4 Global Infertility Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global Infertility Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infertility Diagnosis Market Size (2018-2029)
1.6.1 North America Infertility Diagnosis Market Size (2018-2029)
1.6.2 Europe Infertility Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific Infertility Diagnosis Market Size (2018-2029)
1.6.4 Latin America Infertility Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa Infertility Diagnosis Market Size (2018-2029)
2 Infertility Diagnosis Market by Type
2.1 Introduction
2.1.1 Female Infertility Testing
2.1.2 Male Infertility Testing
2.2 Global Infertility Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infertility Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global Infertility Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infertility Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infertility Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infertility Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infertility Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infertility Diagnosis Revenue Breakdown by Type (2018-2029)
3 Infertility Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Fertility Centers
3.1.4 Research Institutes
3.1.5 Other
3.2 Global Infertility Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infertility Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global Infertility Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infertility Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infertility Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infertility Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infertility Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infertility Diagnosis Revenue Breakdown by Application (2018-2029)
4 Infertility Diagnosis Competition Analysis by Players
4.1 Global Infertility Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infertility Diagnosis as of 2022)
4.3 Date of Key Players Enter into Infertility Diagnosis Market
4.4 Global Top Players Infertility Diagnosis Headquarters and Area Served
4.5 Key Players Infertility Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 Infertility Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Infertility Diagnosis Products, Services and Solutions
5.1.4 Merck Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Procter & Gamble
5.2.1 Procter & Gamble Profile
5.2.2 Procter & Gamble Main Business
5.2.3 Procter & Gamble Infertility Diagnosis Products, Services and Solutions
5.2.4 Procter & Gamble Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Procter & Gamble Recent Developments
5.3 BioMerieux
5.3.1 BioMerieux Profile
5.3.2 BioMerieux Main Business
5.3.3 BioMerieux Infertility Diagnosis Products, Services and Solutions
5.3.4 BioMerieux Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Infertility Diagnosis Products, Services and Solutions
5.4.4 Abbott Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 Babystart
5.5.1 Babystart Profile
5.5.2 Babystart Main Business
5.5.3 Babystart Infertility Diagnosis Products, Services and Solutions
5.5.4 Babystart Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 Babystart Recent Developments
5.6 BioZhena Corporation
5.6.1 BioZhena Corporation Profile
5.6.2 BioZhena Corporation Main Business
5.6.3 BioZhena Corporation Infertility Diagnosis Products, Services and Solutions
5.6.4 BioZhena Corporation Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 BioZhena Corporation Recent Developments
5.7 Quidel Corporation
5.7.1 Quidel Corporation Profile
5.7.2 Quidel Corporation Main Business
5.7.3 Quidel Corporation Infertility Diagnosis Products, Services and Solutions
5.7.4 Quidel Corporation Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Quidel Corporation Recent Developments
5.8 SPD Swiss Precision Diagnostics GmbH
5.8.1 SPD Swiss Precision Diagnostics GmbH Profile
5.8.2 SPD Swiss Precision Diagnostics GmbH Main Business
5.8.3 SPD Swiss Precision Diagnostics GmbH Infertility Diagnosis Products, Services and Solutions
5.8.4 SPD Swiss Precision Diagnostics GmbH Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 SPD Swiss Precision Diagnostics GmbH Recent Developments
5.9 SCSA Diagnostics
5.9.1 SCSA Diagnostics Profile
5.9.2 SCSA Diagnostics Main Business
5.9.3 SCSA Diagnostics Infertility Diagnosis Products, Services and Solutions
5.9.4 SCSA Diagnostics Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 SCSA Diagnostics Recent Developments
5.10 Pride Angel
5.10.1 Pride Angel Profile
5.10.2 Pride Angel Main Business
5.10.3 Pride Angel Infertility Diagnosis Products, Services and Solutions
5.10.4 Pride Angel Infertility Diagnosis Revenue (US$ Million) & (2018-2023)
5.10.5 Pride Angel Recent Developments
6 North America
6.1 North America Infertility Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infertility Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infertility Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infertility Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infertility Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infertility Diagnosis Market Dynamics
11.1 Infertility Diagnosis Industry Trends
11.2 Infertility Diagnosis Market Drivers
11.3 Infertility Diagnosis Market Challenges
11.4 Infertility Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’